Court Grants Correlogic's Motion to Reject Licenses Claimed by AGP
January 21, 2011
Court Grants Correlogic's Motion to Reject Licenses Claimed by AGP
While the court's order is "nonetheless helpful," said Correlogic CEO Peter Levine, the company maintains that AGP "does not have a license to anything."
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Quest Seeks to Stop Sale of Correlogic's Assets, Claims Rights to OvaCheck IP
April 15, 2011 / ProteoMonitor - Court Orders Correlogic to Share IP Info with AGP
December 3, 2010 / ProteoMonitor - AGP Sues Correlogic; Claims Company Defaulted on Loan by Misrepresenting OvaCheck Test
November 19, 2010 / ProteoMonitor - Date, Minimum Bids Set for Sale of Correlogic's Assets
May 27, 2011 / ProteoMonitor - Correlogic Sells AGP Limited Rights to OvaCheck Patents in Asia as Part of Legal Settlement
February 25, 2011 / ProteoMonitor